Mowoot, a start-up and CataloniaBio & HealthTech member, has published its first international clinical trial showing the efficacy and safety of the medical device in treating chronic constipation, regardless of the cause.
It was a multi-centre study carried out with 92 patients over 2 years, funded through the EU Horizon 2020 programme.It was led by Doreen McClurg, a benchmark in the field of neurogenic bowel dysfunction at Glasgow Caledonian University, and Immaculada Herrero-Fresneda, co-founder and CSO of Mowoot.
The results have been published in the journal Clinical and Transalational Gastroenterology.
In addition to the publication of this clinical trial, the company has been entering EU markets recently and is preparing public healthcare reimbursement in Germany and the United Kingdom.
You may also be interested in:
Mowoot opens crowdfunding round to raise €400,000
Want to know more about Mowoot? We recommend this video of CataloniaBio & HealthTech interviewing them:
Comments